HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells.

Abstract
CK2, a pleiotropic Ser/Thr kinase, is an important target for cancer therapy. We tested our novel tenfibgen-based nanocapsule for delivery of the inhibitor 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole (DMAT) and an siRNA directed against both CK2α and α' catalytic subunits to prostate cancer cells. We present data on the TBG nanocapsule itself and on CK2 inhibition or downregulation in treated cells, including effects on Nuclear Factor-kappa B (NF-κB) p65. By direct comparison of two CK2-directed cargos, our data provide proof that the TBG encapsulation design for delivery of drugs specifically to cancer cells has strong potential for small molecule- and nucleic acid-based cancer therapy.
AuthorsJaneen H Trembley, Gretchen M Unger, Vicci L Korman, Diane K Tobolt, Zygmunt Kazimierczuk, Lorenzo A Pinna, Betsy T Kren, Khalil Ahmed
JournalCancer letters (Cancer Lett) Vol. 315 Issue 1 Pg. 48-58 (Feb 01 2012) ISSN: 1872-7980 [Electronic] Ireland
PMID22050909 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightPublished by Elsevier Ireland Ltd.
Chemical References
  • 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole
  • Benzimidazoles
  • RNA, Small Interfering
  • Casein Kinase II
Topics
  • Animals
  • Benzimidazoles (administration & dosage, chemistry, pharmacokinetics)
  • Casein Kinase II (antagonists & inhibitors, genetics, metabolism)
  • Cell Growth Processes (drug effects, genetics)
  • Cell Line, Tumor
  • Down-Regulation
  • Humans
  • Male
  • Mice
  • Prostatic Neoplasms (drug therapy, enzymology, genetics, therapy)
  • RNA, Small Interfering (administration & dosage, genetics, pharmacokinetics)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: